Research progress on the role of ferroptosis in Alzheimer's disease

doi:10.16352/j.issn.1001-6325.2022.07.1129

Abstract

Abstract: Alzheimer's disease (AD) is the most common neurodegenerative disease in the elderly. The symptoms of progressive neuronal loss and death in AD, as well as the hyper-oxidative stress associated with abnormal brain iron levels, may be related to ferroptosis, a new way of cell death. Two characteristics of ferroptosis, iron homeostasis and lipid peroxidation, may potentially link ferroptosis to AD. The research on potential role of ferroptosis may provide new ideas for the treatment of AD.

Key words: Alzheimer's disease(AD), ferroptosis, iron homeostasis disorder, lipid peroxidation

CLC Number:

R741

XU Juan, LI Ye. Research progress on the role of ferroptosis in Alzheimer's disease[J]. Basic & Clinical Medicine, 2022, 42(7): 1129-1133.

References 25

[1]	The Alzheimer's Association. 2021 Alzheimer's disease facts and figures[J]. Alzheimers Dement, 2021, 17: 327-406.
[2]	Gerrits E, Brouwer N, Kooistra SM, et al. Distinct amyloid-β and tau-associated microglia profiles in Alzheimer's disease[J]. Acta Neuropathol, 2021, 141: 681-696.
[3]	张研, 魏来. APPswe/PS1dE9双转基因小鼠中轴突异常与阿尔茨海默病的联系[J].基础医学与临床, 2019, 39: 1525-1529.
[4]	Riegman M, Sagie L, Galed C, et al. Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture[J]. Nat Cell Biol, 2020, 22: 1042-1048.
[5]	Huang L, McClatchy DB, Maher P, et al. Intracellular amyloid toxicity induces oxytosis/ferroptosis regulated cell death[J]. Cell Death Dis, 2020, 11: 828. doi: 10.1038/s41419-020-03020-9.
[6]	Bao WD, Pang P, Zhou XT, et al. Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease[J]. Cell Death Differ, 2021, 28: 1548-1562.
[7]	Ayton S, Wang Y, Diouf I, et al. Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology[J]. Mol Psychiatry, 2020, 25: 2932-2941.
[8]	Stockwell BR, Jiang X, Gu W. Emerging mechanisms and disease relevance of ferroptosis[J]. Trends Cell Biol, 2020, 30: 478-490.
[9]	Butterfield DA. Brain lipid peroxidation and alzheimer disease: synergy between the Butterfield and Mattson laboratories[J]. Ageing Res Rev, 2020, 64: 101049. doi:10.1016/j.arr.2020.101049.
[10]	Han J, Park H, Maharana C, et al. Alzheimer's disease-causing presenilin-1 mutations have deleterious effects on mitochondrial function[J]. Theranostics, 2021, 11: 8855-8873.
[11]	Wang C, Cai X, Wang R, et al. Neuroprotective effects of verbascoside against Alzheimer's disease via the relief of endoplasmic reticulum stress in Abeta-exposed U251 cells and APP/PS1 mice[J]. J Neuroinflammation, 2020, 17: 309. doi: 10.1186/s12974-020-01976-1.
[12]	Kapralov AA, Yang Q, Dar HH, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death[J]. Nat Chem Biol, 2020, 16: 278-290.
[13]	Reis J, Massari M, Marchese S, et al. A closer look into NADPH oxidase inhibitors: validation and insight into their mechanism of action[J]. Redox Biol, 2020, 32: 101466. doi: 10.1016/j.redox.2020.101466.
[14]	Park MW, Cha HW, Kim J, et al. NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases[J]. Redox Biol, 2021, 41: 101947. doi: 10.1016/j.redox.2021.101947.
[15]	Ates G, Goldberg J, Currais A, et al. CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer's disease[J]. Redox Biol, 2020, 36: 101648. doi: 10.1016/j.redox.2020.101648.
[16]	Miyake S, Murai S, Kakuta S, et al. Identification of the hallmarks of necroptosis and ferroptosis by transmission electron microscopy[J]. Biochem Biophys Res Commun, 2020, 527: 839-844.
[17]	Floros KV, Cai J, Jacob S, et al. MYCN-amplified neuroblastoma is addicted to iron and vulnerable to inhibition of the system Xc-/glutathione axis[J]. Cancer Res, 2021, 81: 1896-1908.
[18]	Ashraf A, Jeandriens J, Parkes HG, et al. Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine/glutamate antiporter in Alzheimer's disease: evidence of ferroptosis[J]. Redox Biol, 2020, 32: 101494. doi: 10.1016/j.redox.2020.101494.
[19]	Zhang Y, Swanda RV, Nie L, et al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation[J]. Nat Commun, 2021, 12: 1589. doi: 10.1038/s41467-021-21841-w.
[20]	Zhang HL, Hu BX, Li ZL, et al. PKCβⅡ phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis[J]. Nat Cell Biol, 2022, 24: 88-98.
[21]	Gleason A, Bush AI. Iron and ferroptosis as therapeutic targets in Alzheimer's disease[J]. Neurotherapeutics, 2021, 18: 252-264.
[22]	Zuo Y, Xie J, Li X, et al. Ferritinophagy-mediated ferroptosis involved in paraquat-induced neurotoxicity of dopaminergic neurons: implication for neurotoxicity in PD[J]. Oxid Med Cell Longev, 2021, 2021: 9961628. doi: 10.1155/2021/9961628.
[23]	Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor[J]. Nature, 2019, 575: 693-698.
[24]	Kraft VAN, Bezjian CT, Pfeiffer S, et al. GTP cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling[J]. ACS Cent Sci, 2020, 6: 41-53.
[25]	Mao C, Liu X, Zhang Y, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer[J]. Nature, 2021, 593: 586-590.